Videotaped assessments of standardized interviews were used to ensure blindness in relation to a clinical trial of multifaceted programmes of management in patients with treatment-resistant schizophrenia. The technique, although laborious, was feasible in all patients studied and offered advantages in relation not only to blindness but also to assessing the nature of psychopathological changes in patients with schizophrenic deficit syndrome of severe degree. The method is likely to be useful in further studies assessing the possible advantages of newer antipsychotic drugs.
Carpenter W.T. (1996) The treatment of negative symptoms: pharmacological and methodological issues. Br J Psychiat168 (Suppl 29): 17-22
2.
Carpenter W.T., Heinrich D.W., Wagman A M I (1988) Deficit and non-deficit forms of schizophrenia: the concept. Am J Psychiat145: 578-583
3.
Davison P.S., Frith C.D., Harrison-Read P.E., Johnstone E.C. (1996) Facial and other non-verbal communicative behaviour in chronic schizophrenia. Psychol Med26: 707-713
4.
Dencker S.J., May P R A (1988) From chronic mental hospital care to integration into society. In Dencker S J, Kulhanek F (eds), Treatment resistance in schizophrenia. Vieweg, Braunschweig , pp. 13-21
5.
Johnstone E.C. (1989) The assessment of negative and positive features in schizophrenia. Br J Psychiat155 (Suppl. 7): 41-44
6.
Johnstone E.C., Deakin J F W, Lawler P., Frith CD, Stevens M., McPherson K., Crow TJ ( 1980) The Northwick Park ECT trial. Lancetii: 1317-1320
7.
Kay S.R., Fiszbein A., Opler L.A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull13(2): 261-276
8.
Kirkpatrick B., Buchanan R.W., McKenney P.V., Alphs L.D., Carpenter W.T. (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiat Res30:119-123
9.
Letemendia Fjj, Delva NJ, Rodenburg M., Lawson JS, Inglis J., Waldron JJ, Lynwood DW (1993) Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med23: 349-360
10.
May P R A, Dencker S.J., Hubbard J.W. et al. (1988) A systematic approach to treatment resistance in schizophrenic disorders. In Dencker S J , Kulhanek F (eds), Treatment resistance in schizophrenia. Vieweg, Braunschweig
11.
Meltzer H.Y. (1996) Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review. Br J Psychiat168 (Suppl. 29): 23-31
12.
Mercer G., Finlayson A., Johnstone E.C., Murray C., Owens D G C (1997) A study of enhanced management in patients with treatment resistant schizophrenia. J Psychopharmac11: 349-356
13.
Mueser K.T., Bellack AS (1995) Psychotherapy for schizophrenia. In Hirsch S R, Weinberer DR (eds), Schizophrenia. Blackwell, Oxford
